Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
10 MG prednisone----1件: 44 💬
20 MG tropicamide----1件: 6 💬
30,25 MG RPC1063----1件: 96 💬
40,35% povidone-iodine solution lavage----1件: 46 💬
50,5 MG fingolimod----1件: 13 💬
60.005% lacripep----1件: 53 💬
70.01% lacripep----1件: 53 💬
80.02% FM, SH, 0.05% CSA----1件: 53 💬
90.02% FM, SH, AS----1件: 53 💬
100.02% FM, SH, tbcl----1件: 53 💬
110.03% using A foot pump----1件: 97 💬
120.04 MG LU AE04621----1件: 6 💬
130.05%cyclosporin EYE drop----1件: 38 💬
140.08 MG LU AE04621----1件: 6 💬
150.12% saline----1件: 299 💬
160.2 MG LU AE04621----1件: 6 💬
170.25 MG RPC103----1件: 97 💬
180.25 MG RPC1063----3件: 13, 96, 97 💬
190.25MG RPC103----1件: 97 💬
200.25MG RPC1063----2件: 13, 97 💬
210.3 MG tropicamide----1件: 6 💬
220.4 MG LU AE04621----1件: 6 💬
230.4ML prefilled syringes----1件: 107 💬
240.5 MG budesonide effervescent tablet FOR orodispersible USE1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
250.5 MG RPC1063----2件: 13, 97 💬
260.5% marcaine----1件: 70 💬
270.5MG RPC1063----1件: 13 💬
280.6 MG LU AE04621----1件: 6 💬
290.7ML prefilled syringes----1件: 107 💬
300.8 MG LU AE04621----1件: 6 💬
310.9 % nacl----1件: 124 💬
320.9% chloride injection sodium----1件: 13 💬
330.9% isotonic saline (IS), 4ML----1件: 299 💬
340.9% physiological saline----1件: 266 💬
350.9% saline----2件: 6, 70 💬
360.9% sodium chloride----5件: 6, 14, 51, 53, 65 💬
370.9% sodium chloride injection----2件: 70, 168 💬
380.9% W/V isotonic sodium chloride solution----1件: 50 💬
390.9% W/V sodium chloride solution----1件: 299 💬
400.9ML sodium chloride----1件: 271 💬
410002-8971----1件: 70 💬
42009-0----1件: 6 💬
43009-1----1件: 6 💬
44009-2----1件: 6 💬
45009-3----1件: 6 💬
46009-4----1件: 6 💬
47009-5----1件: 6 💬
48009-A0----1件: 6 💬
49009-A1----1件: 6 💬
50009-A2----1件: 6 💬
51009-A3----1件: 6 💬
520109-0012A 100 MG/ML----1件: 46 💬
530109-0012A 25 MG/ML----1件: 46 💬
540109-0012A 50 MG/ML----1件: 46 💬
550114-0006B----2件: 46, 96 💬
561 - andrographis paniculata P/ST extract----1件: 13 💬
571 food elimination diet----1件: 98 💬
581 food elimination diet therapy----1件: 98 💬
591 infusion OF MSC----1件: 51 💬
601 MG budesonide effervescent tablet FOR orodispersible USE1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
611 MG QD TO 15 MG QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
621 MG RPC1063----2件: 13, 97 💬
631 MG tropicamide----1件: 6 💬
641 MG/KG cnto 136----1件: 49 💬
651 ML 0.9 % nacl----1件: 46 💬
661 serving OF broccoli sprouts----1件: 97 💬
671% lignocaine----1件: 84 💬
681% steroid cream----1件: 13 💬
691) inosine 5'-monophosphate----1件: 17 💬
701,4-benzoxazepin-5(2H)-ONE, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] ----1件: 58 💬
711,4-benzoxazepin-5(2H)-ONE, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] ----1件: 58 💬
721,5 (butylimino)-1,5-dideoxy-D-glucitol----1件: 299 💬
731,5-anhydro-2,3-dideoxy-3-[[(1R,3S)-3-[[7,8-dihydro-3- (trifluoromethyl)-1,6-naphthyridin-6(5H)-YL]C----1件: 46 💬
741- deoxygalactonojirimycin----1件: 19 💬
751-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride----1件: 58 💬
761-(2-isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-D] pyrimidin-4-ONE----1件: 17 💬
771-(6-benzothiazolylsulfonyl)-5-chloro-1H-indole-2-butanoic acid----1件: 51 💬
781-20190----1件: 93 💬
791-22460----1件: 51 💬
801-cyclopropyl-6-fluoro-1,4-dihydro-4-OXO-7-[1-piperazinyl]-3-quinoline carboxylic acid----1件: 299 💬
811-deoxygalactonojirimycin hydrochloride1件: Migalastat2件: Migalastat hydrochloride ,
Migalastat 💬 		1件: GLA 💬 5件: Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬1件: 19 💬
821-deoxynojirimycin hydrochloride1件: Duvoglustat2件: Duvoglustat ,
Duvoglustat hydrochloride 💬 		1件: GAA 💬 3件: Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬1件: 256 💬
831-{6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-YL)OXY]-3-pyridinyl}-2-pyrrolidinone----1件: 13 💬
841.0 G vancomycin powder into THE wound----1件: 46 💬
851.0 MG LU AE04621----1件: 6 💬
861.0 MG rasagiline mesylate1件: Rasagiline3件: Rasagiline mesylate ,
Rasagiline ,
Rasagiline tartrate 💬 		1件: MAO 💬 13件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬1件: 6 💬
871.0 MG RPC103----1件: 97 💬
881.0 MG RPC1063----1件: 97 💬
891.0 MIU IL-2 PER DAY----1件: 2 💬
901.0MG RPC1063----1件: 13 💬
911.2 MG LU AE04621----1件: 6 💬
921.2 MG ZGN-440 FOR injectable suspension----1件: 193 💬
931.5 X 10^6 UC-MSC + CM----1件: 90 💬
941.8 MG ZGN-440 FOR injectable suspension----1件: 193 💬
951.remicade1件: Infliximab1件: Infliximab 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 97 💬
9610 MG----1件: 96 💬
9710 MG natura-alpha capsule----1件: 97 💬
9810 MG/KG CM-101----1件: 51 💬
9910 MG/KG cnto 136----1件: 49 💬
10010% liquid formulation OF human immunoglobulin----1件: 14 💬
10110% nifedipine cream----1件: 50 💬
10210% nitroglycerine IN propylene glycol, USP1件: Nitroglycerin1件: Nitroglycerin 💬 --1件: 51 💬
10310-MG dose OF E5501 2G tablet----1件: 63 💬
10410-MG dose OF E5501 cyclodextrin oral solution----1件: 63 💬
10510-MG dose OF E5501 lipid-based oral----1件: 63 💬
10610-MG dose OF E5501-P21% powder----1件: 63 💬
10710-nitro-9(E)-octadec-9-enoic acid1件: CXA-10---1件: 86 💬
108100 MG----4件: 46, 96, 97, 271 💬
109100 MG AP1189----2件: 46, 222 💬
110100 MG ELX (VX-445) / 50 MG TEZ / 75 MG IVA FDC----1件: 299 💬
111100 MG ELX /50 MG TEZ /75 MG IVA FDC----1件: 299 💬
112100 MG ELX/50 MG TEZ /75 MG IVA FDC----1件: 299 💬
113100 MG ELX/50 MG TEZ/75 MG IVA fixed dose combination----1件: 299 💬
114100 MG LX3305 QD----1件: 46 💬
115100 MG TEZ/150 MG IVA FDC----1件: 299 💬
116100 MG VX-445 /50 MG TEZ/75 MG IVA FDC----1件: 299 💬
117100 MG VX-445/50 MG TEZ /75 MG IVA FDC----1件: 299 💬
118100 MG/M2 dose----1件: 299 💬
119100 µG brimonidine tartrate implant----1件: 90 💬
120100 µG KIO-301----1件: 90 💬
121100% OF individual calory requirement----1件: 2 💬
122100% pomegranate juice----2件: 96, 97 💬
123100-MG ELX (VX-445) / 50-MG TEZ / 75-MG IVA FDC----1件: 299 💬
124100-MG ELX (VX-455) / 50-MG TEZ / 75-MG IVA FDC----1件: 299 💬
125100-MG ELX / 50-MG TEZ / 75 -MG IVA FDC----1件: 299 💬
126100-MG VX-445 / 50-MG TEZ / 75- MG IVA FDC----1件: 299 💬
127100-MG VX-445 / 50-MG TEZ / 75-MG IVA FDC----1件: 299 💬
128100-MG VX-445 /50-MG TEZ/75-MG----1件: 299 💬
129100-MG VX-445/50-MG TEZ/75-MG IVA FDC----1件: 299 💬
1301000 IU D3----1件: 96 💬
13110000IU vitamin D----1件: 13 💬
1321000MG RTX group----1件: 46 💬
133100G ELX / 50MG TEZ / 75MG IVA----1件: 299 💬
134100MG ELX/50MG TEZ /75MG IVA----1件: 299 💬
135100MG FHND1002----1件: 2 💬
136100MG VX-445/50MG TEZ /75MG IVA FDC----1件: 299 💬
1371064NM laser----1件: 34 💬
1381064NM ND:YAG laser----1件: 34 💬
13911-ß-hydroxysteroid dehydrogenase type 1----1件: 75 💬
140111jc101----1件: 25 💬
141118-42-3----2件: 46, 49 💬
14211C-acetate1件: Acetic acid C-11---3件: 13, 86, 88 💬
14311C-BMS-986196----1件: 13 💬
14411C-csar----2件: 93, 94 💬
14511C-flumazenil----1件: 206 💬
14611C-MC1----3件: 6, 13, 46 💬
14711C-methionine PET/CT1件: Methionine C-11---1件: 75 💬
14811C-PBR28----2件: 6, 13 💬
14911C-PIB----5件: 5, 6, 7, 13, 17 💬
15011C-PS13----2件: 6, 13 💬
15111C-raclopride----4件: 5, 6, 7, 17 💬
15211C-UCB-J----1件: 6 💬
15311C-UCB-J PET-CT----1件: 8 💬
15412 lead electrocardiogram----1件: 19 💬
15512 MG/KG GSK2402968----1件: 113 💬
15612-lead ECG----3件: 58, 140, 144 💬
15712-month questionnaire----1件: 299 💬
158120 MG sodium nitrite inhalation solution----1件: 86 💬
159120% OF individual calory requirement----1件: 2 💬
160124I-AT03----1件: 28 💬
161124I-evuzamitide----1件: 70 💬
162124I-labeled monoclonal antibody MU 11-1f4----1件: 28 💬
163124I-P5+14 injection----1件: 28 💬
164129XE----1件: 299 💬
165129XE hyperpolarized----1件: 86 💬
166129XE small and large human lung coil----1件: 299 💬
16712S-IT----1件: 19 💬
16813 valent conjugated pneumococcal vaccine----1件: 265 💬
16913-15MG/KG/D ursodeoxycholic----1件: 93 💬
17013-PCV booster----1件: 13 💬
17113-valent pneumococcal conjugate vaccine----2件: 46, 53 💬
17213c6 leucine----3件: 5, 7, 127 💬
17313N-ammonia----2件: 6, 17 💬
17413nh3 PET/CT scan----1件: 84 💬
17515 MG QD DE-escalated TO 7 MG QD PF-06649751 IN parent study remain AT 7 MG QD1件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
17615 MG sodium nitrite inhalation solution----1件: 86 💬
17715 or 45 MG----1件: 67 💬
17815-0 H20----2件: 6, 19 💬
17915-DAY taper prednisone----1件: 46 💬
18015-O labeled water----1件: 46 💬
181150 MG double-blinded secukinumab----1件: 271 💬
182150 MG FHND1002----1件: 2 💬
183150 MG GSK1265744B----1件: 265 💬
184150 MG LX3305 QD----1件: 46 💬
185150 MG OPEN-label secukinumab----1件: 271 💬
186150% OF their routine home dopaminergic medications dose right IN THE clinic----1件: 6 💬
187150-DAY taper prednisone----1件: 46 💬
188150-MG ivacaftor1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
1891500MG mesalazine pellets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
190150MG CXA-10----1件: 86 💬
191150MG ivacaftor1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
19215n2-tofacitinib----1件: 97 💬
19315O H2O----1件: 6 💬
19416,5% cutaquig----1件: 65 💬
1951629063-78-0----1件: 19 💬
1961643368-58-4----2件: 53, 160 💬
19717,21-dihydroxypregna-1,4-diene-3,11,20-trione----1件: 41 💬
19817ß-hydroxy-11ß-(4-dimethylaminophenyl)17A-(PROP-1-ynyl)estra-4,9-DIEN-3-ONE----1件: 75 💬
19918 FDG----1件: 145 💬
20018-22MG/KG/D ursodeoxycholic----1件: 93 💬
20118-fdtbz----1件: 6 💬
20218F florbetaben----1件: 6 💬
20318F- dtbz----1件: 6 💬
20418F-AV-1331件: Florbenazine F-18---1件: 6 💬
20518F-AV-1451----3件: 5, 7, 127 💬
20618F-AV-45----2件: 6, 127 💬
20718F-dopa----3件: 6, 17, 75 💬
20818F-dopa PET----1件: 6 💬
20918F-dopamine----2件: 6, 17 💬
21018F-DPA-714 and 18F-FDG----1件: 13 💬
21118F-dtbz----1件: 6 💬
21218F-dtbz AV-133----1件: 6 💬
21318F-FDG1件: Fludeoxyglucose (18F)1件: Fludeoxyglucose F 18 💬 --8件: 5, 6, 7, 46, 84, 85, 127, 300 💬
21418F-FDG and 68GA-fapi PET/CT1件: Fludeoxyglucose (18F)1件: Fludeoxyglucose F 18 💬 --1件: 96 💬
21518F-FDG PET-MR1件: Fludeoxyglucose (18F)1件: Fludeoxyglucose F 18 💬 --1件: 8 💬
21618F-FDG PET/CT1件: Fludeoxyglucose (18F)1件: Fludeoxyglucose F 18 💬 --1件: 41 💬
21718F-FDG-PET/MRI1件: Fludeoxyglucose (18F)1件: Fludeoxyglucose F 18 💬 --1件: 84 💬
21818F-fgln PET imaging----1件: 86 💬
21918F-florbetaben----1件: 6 💬
22018F-fluoro-L-dopa----1件: 6 💬
22118F-fluorodeoxyglucose----1件: 84 💬
22218F-fluorodeoxyglucose (18F-FDG) PET/CT----1件: 84 💬
22318F-fspg1件: Florilglutamic acid F-18---1件: 84 💬
22418F-FTC-146----1件: 206 💬
22518F-GE-1801件: Flutriciclamide F-18---1件: 46 💬
22618F-GE180-PET/MRI----1件: 84 💬
22718F-OP-801----3件: 2, 6, 13 💬
22818F-PBR06----1件: 17 💬
22918F-PM-PBB3----1件: 13 💬
23018F-RO6958948----3件: 5, 7, 127 💬
23118F-SMBT-1----1件: 6 💬
23218FDG PET scan----1件: 41 💬
23318FDG PET/CT scan----1件: 84 💬
23419 NOR vitamin D----1件: 13 💬
2351[(6- allyl- 8ß- ERG----1件: 6 💬
2361[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea----1件: 6 💬
2371H-pyrazol1件: Pyrazole---2件: 2, 75 💬
2381H/31P magnetic resonance spectroscopy----1件: 77 💬
2391MG budesonide effervescent tablet FOR orodispersible USE1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
2401MG RPC1063----1件: 96 💬
2411MG/KG/HR TXA intravenous infusion till THE last suture----1件: 70 💬
2421ML prefilled syringes----1件: 107 💬
2432 - excipients----1件: 13 💬
2442 infusions OF MSC----1件: 51 💬
2452 MA transcranial direct current stimulation----1件: 13 💬
2462 MG perampanel----1件: 6 💬
2472 million hmsc/KG----1件: 46 💬
2482 X 10 MG natura-alpha capsules----1件: 97 💬
2492% chlorhexidine solution wipes1件: Chlorhexidine4件: Chlorhexidine gluconate ,
Chlorhexidine hydrochloride ,
Chlorhexidine ,
Chlorhexidine acetate 💬 		--1件: 299 💬
2502% lignocaine----1件: 84 💬
2512% sodium chondroitin sulfate----1件: 226 💬
2522',4'-difluoro-4-hydroxy-3-biphenylcarboxylic acid1件: Diflunisal1件: Diflunisal 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬1件: 28 💬
2532'-fucosyllactose----2件: 96, 97 💬
2542'-O-(2-methoxyethyl) phosphorothioate antisense oligonucleotide targeting CD49D RNA----1件: 113 💬
2552'-O-(2-methoxyethyl)-D-ribose antisense oligonucleotide targeting----1件: 131 💬
2562'-O-(2-methoxyethyl)-D-ribose antisense oligonucleotide targeting glial fibrillary acidic protein messenger ribonucleic acid----1件: 131 💬
2572(S)-(acetylamino)-4-methylpentanoic acid----2件: 19, 65 💬
2582,3-dihydroxybutanedioic acid----1件: 299 💬
2592,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-YL)-4,6-dimethylpyridine-1-oxide----1件: 6 💬
2602-(((2E)-3-(3-methoxy-4-(2-propyn-1-yloxy)phenyl)-1-OXO-2-propen-1-YL)amino)benzoic acid----1件: 51 💬
2612-(2-(2-amino-9H-purin-9-YL)ethyl)-1,3-propanediol diacetate ester1件: Famciclovir1件: Famciclovir 💬 --1件: 13 💬
2622-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylat----1件: 28 💬
2632-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate----1件: 28 💬
2642-(4-[5,6-diphenylpyrazin-2-YL)(isopropyl)amino]butoxy)-N-(methylsulfonyl)actamide----1件: 86 💬
2652-[(E)-[(E)-3-[1-(2-nitrophenyl)pyrrol-2-YL]PROP-2-enylidene]amino]guanidine----1件: 46 💬
2662-[4-[(2-amino-5-methyl-4-OXO-1,6,7,8-tetrahydropteridin-6-YL)methylam INO]benzoyl]amino----1件: 337 💬
2672-[[[(2R)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4- piperidinyl]-5-OXO-2-pyrrolidinyl]carbonyl]amino]- N,N,6-trimethyl-4-pyridinecarboxamide,dihydrochloride----2件: 6, 162 💬
2682-amino-4-(methyl[11C]sulfanyl)butanoic acid----1件: 34 💬
2692-aminoethanethiol1件: Cysteamine3件: Cysteamine ,
Cysteamine hydrochloride ,
Cysteamine bitartrate 💬 		--2件: 19, 299 💬
2702-CDA1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2712-CDA, 2-chloro-2'-deoxy-ß-D-adenosine1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2722-CDA, 2-chloro-2?-deoxy-ß-D-adenosine1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2732-CDA, 2-chloro-2’-deoxy-ß-D-adenosine1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2742-chloro-2'-deoxyadenosine, 2CDA1件: Cladribine1件: Cladribine 💬 1件: RRM1 💬 4件: Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬1件: 13 💬
2752-chloro-2?-deoxy-ß-D-adenosine----1件: 13 💬
2762-chloro-2’-deoxy-ß-D-adenosine----1件: 13 💬
2772-deoxy-2 [F-18] fluoro-2-D-glucose----1件: 49 💬
2782-hoba1件: 2-(aminomethyl)phenol---2件: 46, 86 💬
2792-hour holter monitor----1件: 19 💬
2802-hydroxypropyl-BETA-cyclodextrin1件: Hydroxypropyl betadex---1件: 19 💬
2812-isopropyl-3H-naphtho[2,1-D]imidazole-4,5-dione----1件: 21 💬
2822-{4-[(5,6-diphenylpyrazin-2-YL)(isopropyl)amino]butoxy}-N-(methylsulfonyl) acetamide----1件: 86 💬
2832-{7-[1,1-dimethyl-3-(4-sulfobutyl)-benz[E]indolin-2-ylidene]-1,3,5-heptatrienyl}-1,1-dimethyl-3-(sulfobutyl)-1H-benz[E]-indolium hydroxide,inner salt----1件: 46 💬
2842-{[(8Z)-13-[(methylcarbamoyl)formamido]- tridec-8-EN-1-YL]OXY}acetic acid----1件: 21 💬
2852-{[(8Z)-13-[(methylcarbamoyl)formamido]-tridec-8-EN-1-YL]OXY}acetic acid----1件: 21 💬
2862.0 MIU IL-2 PER DAY----1件: 2 💬
28720 MG----1件: 97 💬
28820 MG BID OF PF-02545920----1件: 8 💬
28920 MG GA----1件: 13 💬
29020 MG mitoq----1件: 13 💬
29120 MG/ML treprostinil1件: Treprostinil3件: Treprostinil ,
Treprostinil monosodium salt ,
Treprostinil diolamine 💬 		1件: PTGIR 💬 3件: Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬1件: 86 💬
292200 MG BIA 6-512----1件: 6 💬
293200 MG LX3305 QD----1件: 46 💬
294200 MG/M2 dose----1件: 299 💬
295200 µG brimonidine tartrate implant----1件: 90 💬
296200-1600 µG OF MBX 2109 ONCE-weekly BY subcutaneous injection----1件: 235 💬
297200106 or EMD 28162----1件: 13 💬
298200MG cannabidiol BY capsules twice daily----1件: 46 💬
2992011-2012 seasonal FLU vaccine intramuscular----2件: 3, 113 💬
3002011-2012 seasonal FLU vaccine subcutaneous----2件: 3, 113 💬
3012019171-69-6----1件: 61 💬
302207-3120----1件: 6 💬
30320MG daily citalopram----1件: 8 💬
30420MG/0.5ML GA----1件: 13 💬
30520MG/0.5ML glatiramer acetate1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
30620MM sodium pyruvate nasal spray----1件: 85 💬
30723-PPV----1件: 13 💬
30823-valent pneumococcal polysaccharide vaccine----3件: 13, 46, 53 💬
30923-valent polysaccharide pneumococcal vaccine----2件: 96, 97 💬
31024 hour copper IN urine and liver function test----1件: 171 💬
31124-hour urine test----1件: 75 💬
312240MG amantadine HCL ER tablets----1件: 6 💬
31325 MG BIA9 1067----1件: 6 💬
31425 MG ongentys----1件: 6 💬
31525 MG ontamalimab----2件: 96, 97 💬
31625% MTD sodium nitrite inhalation solution----1件: 86 💬
31725(OH)D3----1件: 13 💬
318250 MG CK-2017357----2件: 2, 11 💬
319250 MG LX3305 BID----1件: 46 💬
320250 MG LX3305 QD----1件: 46 💬
321250MG FHND1002----1件: 2 💬
322250MG mesalazine pellets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
32325OH-vitamin D1件: Cholecalciferol1件: Cholecalciferol 💬 1件: VDR 💬 5件: Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬1件: 13 💬
32426 common fabry mutation types IN taiwan----1件: 19 💬
3252622u90 duramycin1件: Lancovutide---1件: 299 💬
32629180.00.00, 34681.00.00, 34681.01.00, 34681.02.00----1件: 113 💬
3272b3-201----1件: 13 💬
3282L polyethylene glycol/ascorbic acid----1件: 97 💬
3292MG budesonide effervescent tablet FOR orodispersible USE1件: Budesonide1件: Budesonide 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 98 💬
3302MG CS0159----1件: 93 💬
3312ML peripheral venous blood WAS collected TO detect genetic genes----1件: 97 💬
3322S,4R-(-)-ketoconazole----1件: 75 💬
3332S,4R-(-)-ketoconazole, levoketoconazole----1件: 75 💬
3343 bottles OF lactulose oral solution----1件: 97 💬
3353 MG----1件: 299 💬
3363 MG [14C]-A4250 capsule----3件: 93, 297, 338 💬
3373 MG melatonin----1件: 13 💬
3383 MG QD TO 15 MG QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
3393 MG/KG GSK2402968----1件: 113 💬
3403 mpdn pulse + PDN + CSA----1件: 50 💬
3413 mpdn pulse + PDN + MTX----1件: 50 💬
3423 servings OF broccoli sprouts----1件: 97 💬
3433 tesla MRI----1件: 127 💬
3443'mrna sequencing----1件: 41 💬
3453,4-diaminopyridine----2件: 12, 13 💬
3463,4-diaminopyridine phosphate1件: Phosphate ion---1件: 3 💬
3473- (9,10- didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate----1件: 6 💬
3483-(3,4-dihydroxyphenyl)-L-alanine----1件: 6 💬
3493-(3-(3,5-dimethyl-1H-pyrazol-4-YL)propoxy)-4-fluorobenzoic acid----1件: 28 💬
3503-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-YL]methyl}amino)pentanedioic acid----1件: 93 💬
3513-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt----2件: 51, 85 💬
35230 or 60 MG----1件: 67 💬
35330 or 90 MG----1件: 67 💬
35430 seconds SIT TO stand test----1件: 113 💬
35530-hour ambulatory sampling OF intestinal fluid----1件: 83 💬
356300 MG double-blinded secukinumab----1件: 271 💬
357300 MG LX3305 QD----1件: 46 💬
358300MG gemcabene----1件: 265 💬
35931-phosphorus RMN spectroscopy----1件: 8 💬
360320MG amantadine HCL ER tablets----1件: 6 💬
361331731-18-1----5件: 46, 96, 97, 107, 271 💬
36235MG----2件: 50, 107 💬
3633A,7A-dihydroxy-6A-ethyl-5ßcholan-24-OIC acid----1件: 93 💬
3643H-cholesterol bound TO albumin----2件: 259, 261 💬
3653HE human lung coil----1件: 299 💬
3663k3A-APC protein----1件: 2 💬
3673L-polyethylene glycol----1件: 97 💬
3683TC----2件: 265, 325 💬
3694 cholesten-3-ONE, oxime----1件: 2 💬
3704 food elimination diet----1件: 98 💬
3714 MA transcranial direct current stimulation----1件: 13 💬
3724 MG perampanel----1件: 6 💬
3734 MG/KG cnto 136----1件: 49 💬
3744 million hmsc/KG----1件: 46 💬
3754% chlorhexidine gluconate liquid skin cleanser----1件: 299 💬
3764'-chloro-2'-cyano-N-(trans-4-hydroxy-4-methylcyclohexyl)-biphenyl-4-sulphonamide----1件: 46 💬
3774'-IODO-4'-deoxydoxorubicin----1件: 28 💬
3784-(pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-ONE----1件: 58 💬
3794-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2H)-ONE----1件: 58 💬
3804-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-benzamide, methane sulphonic acid salt. AB1010base----1件: 2 💬
3814-[5-(4-methylphenyl)-3-(trifluoromethyl)- 1H-pyrazol-1-YL] benzenesulfonamide----1件: 46 💬
3824-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-YL] benzenesulfonamide----1件: 46 💬
3834-aminopyridine1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬2件: 3, 13 💬
3844-aminosalicylic acid----1件: 96 💬
3854-aminosalicylic acid extended release granules----1件: 96 💬
3864-AP1件: Dalfampridine1件: Dalfampridine 💬 4件: KCNA4,
KCNC3,
KCND2,
KCND3 💬 		4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬1件: 13 💬
3874-benzyl-2-naphtalen-1-YL-1,2,4-thiadiazolidine-3,5-dione----1件: 5 💬
3884-benzyl-2-naphthalen-1-YL-1,2,4- thiadiazolidine-3,5-dione----1件: 113 💬
3894-benzyl-2-naphthalen-1-YL-1,2,4-thiadiazolidine-3,5-dione----1件: 113 💬
3904-cholesten-3-ONE, oxime1件: Olesoxime1件: Olesoxime 💬 --2件: 2, 3 💬
3914-cholesten-3-ONE,oxime----1件: 3 💬
3924-methylpyrazole1件: Fomepizole1件: Fomepizole 💬 3件: ADH1_7,
ADH1_7,
ADH1_7 💬 		8件: Alcoholic liver disease, Drug metabolism - cytochrome P450, Fatty acid degradation, Glycolysis / Gluconeogenesis, Metabolism of xenobiotics by cytochrome P450, Pyruvate metabolism, Retinol metabolism, Tyrosine metabolism 💬1件: 301 💬
3934-PBA----1件: 231 💬
3944-{[(1R,2S,3S,5S,7S)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-B]pyridine-5-carboxamide monohydrobromide----1件: 46 💬
3954.2% nacl----1件: 340 💬
3964.2% nacl/inhalation solution----2件: 299, 340 💬
3974.5 MG naltrexone1件: Naltrexone2件: Naltrexone hydrochloride ,
Naltrexone 💬 		3件: OPRD1,
OPRK1,
OPRM1 💬 		7件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
39840 MG----1件: 96 💬
39940 MG GA----2件: 2, 13 💬
40040 MG glatiramer acetate1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬2件: 2, 13 💬
40140 MG glatiramer acetato1件: Glatiramer1件: Glatiramer acetate 💬 20件: MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC1,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2,
MHC2 💬 		32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬1件: 13 💬
40240 MG MSB11022----5件: 46, 96, 97, 107, 271 💬
40340 MG- soluzione iniettabile IN siringhe PRE-riempite- USO sottocutaneo- siringa preriempita (0,4ML)- 2 siringhe PRE-riempite + 2 tamponi imbevuti DI alcool----1件: 107 💬
404400 MG BIA 5-1058----1件: 86 💬
405400 MG LX3305 QD----1件: 46 💬
406400 µG brimonidine tartrate implant----1件: 90 💬
407400 µG OF MBX 2109 ONCE-weekly BY subcutaneous injection----1件: 235 💬
408400MG cannabidiol BY capsules twice daily----1件: 46 💬
40940MG OF mitoq----1件: 13 💬
41040MG triamcinolone injections IN THE bladder----1件: 226 💬
41144/154/85-C----1件: 50 💬
41244/196/81-C----1件: 50 💬
41345 GY external radiations----1件: 94 💬
41445 MG sodium nitrite inhalation solution----1件: 86 💬
4154au76----1件: 86 💬
4164D-125 IVT injection----1件: 90 💬
4174D-3101件: 4D-310---1件: 19 💬
4184D-710----1件: 299 💬
4195 ASA, enemas, suppositories, corticosteroids----1件: 97 💬
4205 MG melatonin----1件: 13 💬
4215 MG montelukast1件: Montelukast2件: Montelukast sodium ,
Montelukast 💬 		1件: CYSLTR1 💬 2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬1件: 98 💬
4225 MG prednisone----1件: 44 💬
4235% glucose water solution----1件: 2 💬
4245% lidocaine/5 MG/ML 0.02% estradiol compound cream----1件: 226 💬
4255% sildenafil cream----1件: 50 💬
4265,6,7,8-tetrahydrobiopterin1件: Sapropterin2件: Sapropterin dihydrochloride ,
Sapropterin 💬 		--1件: 240 💬
4275-(ethylsulfonyl)-2-(naphthalen-2-YL)benzo[D]oxazole----1件: 113 💬
4285-[4-[2-(5-(1-hydroxyethyl)-2- pyridinyl)ethoxy]benzyl]-2,4- thiazolidinedione hydrochloride----1件: 20 💬
4295-[4-[2-(5-(1-hydroxyethyl)-2-pyridinyl)ethoxy]benzyl]-2,4-thiazolidinedione hydrochloride----1件: 20 💬
4305-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione hydrochloride----1件: 20 💬
4315-ALA1件: Aminolevulinic acid2件: Aminolevulinic acid hydrochloride ,
Aminolevulinic acid 💬 		--2件: 54, 180 💬
4325-amino salicylic acid----1件: 97 💬
4335-amino-2-hydroxybenzoic acid----1件: 97 💬
4345-aminolevulinic acid----1件: 96 💬
4355-aminosalicyclic acid----1件: 97 💬
4365-aminosalicyl acid----1件: 96 💬
4375-aminosalicylic acid1件: Mesalazine1件: Mesalamine 💬 --2件: 96, 97 💬
4385-aminosalicylic acid(5-ASA) and/or prednisone1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
4395-ASA1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
4405-ASA MMX1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
4415-chlor-6'-methyl- 3-[4-(methylsulfonyl)phenyl]- 2,3'-bipyridin----2件: 46, 271 💬
4425-chloro-1,2-dihydro-N-ethyl-4-hydroxy-1-methyl-2-OXO-N-phenyl-3-quinolinecarboxamide sodium----1件: 8 💬
4435-HTP----2件: 96, 97 💬
4445-hydroxytryptophan / vitamin B6----1件: 206 💬
4455-methyl-1-phenyl-2-1-(H)-pyridone----1件: 228 💬
4465-methyltetrahydrofolate and vitamin B12----1件: 299 💬
4475-mthf----1件: 337 💬
4485-probe cocktail----1件: 254 💬
4495-year follow-UP DPA-714-PET/MRI----1件: 6 💬
45050 MG----1件: 97 💬
45150 MG AP1189----1件: 46 💬
45250 MG BIA 9 1067----1件: 6 💬
45350 MG ELX/25 MG TEZ/37.5 MG IVA----1件: 299 💬
45450 MG ELX/25 MG TEZ/37.5 MG IVA fixed dose combination----1件: 299 💬
45550 MG etanercept1件: Etanercept1件: Etanercept 💬 2件: LTA,
TNF 💬 		66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬1件: 46 💬
45650 MG LX3305 QD----1件: 46 💬
45750 MG ongentys----1件: 6 💬
45850 patients will have A free choice between filgotinib and anti TNF1件: Filgotinib2件: Filgotinib ,
Filgotinib maleate 💬 		4件: JAK1,
JAK2,
JAK3,
TYK2 💬 		39件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬1件: 46 💬
45950 µG KIO-301----1件: 90 💬
460500 0500 0----1件: 19 💬
461500 MG CK-2017357----2件: 2, 11 💬
462500 MG LX3305 QD----1件: 46 💬
4635000 IU D3----1件: 96 💬
4645000 IU OF cholecalciferol----1件: 299 💬
4655000IU vitamin D----1件: 13 💬
466500MG mesalazine pellets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
467500MG RTX group----1件: 46 💬
46850MG FHND1002----1件: 2 💬
46952069.00.01----1件: 13 💬
470534-1508----1件: 85 💬
471549-0261/F02-01----2件: 96, 97 💬
472552-02----2件: 53, 299 💬
47356/104/75-C----1件: 50 💬
4745MG----2件: 50, 107 💬
4756 alpha-ethylchenodeoxycholic acid (6-edca), OCA, INT-747----1件: 93 💬
4766 food elimination diet therapy----1件: 98 💬
4776 mercaptopurine----2件: 96, 97 💬
4786 MG/KG GSK2402968----1件: 113 💬
4796 million hmsc/KG----1件: 46 💬
4806 months weight resistance and balance program----1件: 13 💬
4816% hypertonic saline (HS), 4ML----1件: 299 💬
4826-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine----1件: 38 💬
4836-(nitrooxy)hexyl(2Z)-4-(acetyloxy)-3-[4-(methylsulfonyl)phenyl]-2-phenylbut-2-enoate----1件: 46 💬
4846-[(methyl-4-nitro-1H-imidazol-5-YL)thio]-1H-purine----1件: 96 💬
4856-[18F]fluorodopa----1件: 6 💬
4866-[18F]fluorodopamine----1件: 6 💬
4876-[2-(3,4-diethoxyphenyl)thiazol-4-YL] pyridine-2-carboxylic acid----1件: 97 💬
4886-ecdca1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
4896-ethynyl-1-(pentan-3-YL)-1H-imidazo[4,5-B]pyrazin-2(3H)-ONE----1件: 2 💬
4906-mercaptopurine1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬 		1件: hprT 💬 2件: Drug metabolism - other enzymes, Purine metabolism 💬3件: 96, 97, 164 💬
4916-minute walk distance (6MWD) test----2件: 86, 88 💬
4926-minute walk distance (6MWD) test ON ambient AIR----2件: 86, 88 💬
4936-minute walk distance test with supplemental oxygen----2件: 86, 88 💬
4946-MP1件: Mercaptopurine2件: Mercaptopurine ,
Mercaptopurine 💬 		1件: hprT 💬 2件: Drug metabolism - other enzymes, Purine metabolism 💬2件: 96, 97 💬
49560% oxygen----1件: 85 💬
49660-minutes OF steady state exercise----1件: 265 💬
497600MG gemcabene----1件: 265 💬
498608 dose A----1件: 271 💬
499608 dose B----1件: 271 💬
500608 dose C----1件: 271 💬
50164CU-dotatate PET/CT scan1件: Copper oxodotreotide Cu-64---1件: 84 💬
50264cucl2----1件: 171 💬
50366215-101----1件: 86 💬
50468-GA HA-dotatate PET/CT----1件: 41 💬
50568GA-BMV101----1件: 85 💬
50668GA-bnota-PRGD2----1件: 46 💬
50768GA-DOTA-tate PET/MR and PET/CT imaging----1件: 238 💬
50868GA-DOTA-TOC PET/CT----1件: 84 💬
50968GA-dotanoc----1件: 84 💬
51068GA-dotatate2件: Dotatate,
Dotatate gallium Ga-68		1件: Edotreotide gallium Ga-68 💬 1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 75 💬
51168GA-dotatate PET/CT1件: Dotatate gallium Ga-681件: Edotreotide gallium Ga-68 💬 1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 84, 238 💬
51268GA-dotatate PET/MRI1件: Dotatate gallium Ga-681件: Edotreotide gallium Ga-68 💬 1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 19 💬
51368GA-fapi----3件: 46, 97, 300 💬
51468GA-NEB----3件: 46, 89, 280 💬
51568GA-P16-093----1件: 53 💬
51668ganota-ANTI-MMR-VHH2----1件: 84 💬
5176?-ethylchenodeoxycholic acid (6-ecdca), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
5186A-ethylchenodeoxycholic acid (6-ecdca), OCA, INT-7471件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
5196A-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
5206A-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-O1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
5216A-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
5226A-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-O1件: Obeticholic acid1件: Obeticholic acid 💬 1件: NR1H4 💬 1件: Bile secretion 💬1件: 93 💬
5236Aß - apomorphine-10,11-diol hydrochloride hemihydrate1件: Apomorphine2件: Apomorphine hydrochloride ,
Apomorphine 💬 		2件: DRD1,
DRD2 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 6 💬
5246R-BH41件: Sapropterin2件: Sapropterin dihydrochloride ,
Sapropterin 💬 		--2件: 86, 124 💬
5257 MG QD TO 15 MG QD PF-066497511件: Tavapadon1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5267% hypertonic saline VIA nebulization----1件: 299 💬
5277% nacl----1件: 299 💬
5287% saline----1件: 299 💬
5297-BETA-hydroxyepiandrosterone1件: 7-beta-Hydroxyepiandrosterone---1件: 6 💬
5307-valent pneumococcal conjugate vaccine----1件: 46 💬
53170930.00.00----1件: 46 💬
53275 MG ontamalimab----2件: 96, 97 💬
53375-MG ivacaftor1件: Ivacaftor1件: Ivacaftor 💬 1件: CFTR 💬 8件: ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬1件: 299 💬
534750MG mesalazine pellets1件: Mesalazine1件: Mesalamine 💬 --1件: 97 💬
535755NM alexandrite laser----1件: 34 💬
53675MG CXA-10----1件: 86 💬
53776517-01-4----1件: 77 💬
5388-ohdg1件: 8-hydroxy-2'-deoxyguanosine---1件: 6 💬
53980 MG DR-6MP----1件: 96 💬
540800 MG ibuprofen/26.6 MG famotidine----1件: 107 💬
54180MG ELX / 40MG TEZ / 60MG IVA----1件: 299 💬
54281409-90-7----1件: 77 💬
54381MG aspirin----1件: 49 💬
54489 ZR-DF-crefmirlimab----2件: 13, 25 💬
54589ZR-bevacizumab2件: Bevacizumab,
Bevacizumab zirconium Zr-89		1件: Bevacizumab 💬 1件: VEGFA 💬 23件: AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬1件: 34 💬
54689ZR-DFO-AP-101----1件: 2 💬
54789ZR-DFO-CZP----1件: 46 💬
54889ZR-SBC-1031件: Lesinidase alfa1件: Lesinidase alfa 💬 1件: NAGLU 💬 2件: Glycosaminoglycan degradation, Lysosome 💬1件: 19 💬
5499 MG/KG GSK2402968----1件: 113 💬
5509-chloro-2,3-dimethyl-6-(N,N-dimethylaminoethylamino-2-oxoethyl)-6H-indolo[2,3-B] quinoxaline----1件: 46 💬
5519-CIS, 12-CIS-11,11-D2-linoleic acid ethyl ester----2件: 2, 5 💬
55290 MG hydrocortisone acetate suppository with sephure suppository applicator3件: Acetate,
Hydrocortisone,
Hydrocortisone acetate		2件: Hydrocortisone ,
Hydrocortisone acetate 💬 		1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 💬1件: 97 💬
55390 MG idrocortisone acetato IN supposta CON applicatore PER supposte sephure----1件: 97 💬
55490 MG sodium nitrite inhalation solution----1件: 86 💬
555900MG teta 4HCL once daily formulation1件: Triethylenetetramine2件: Trientine hydrochloride ,
Trientine tetrahydrochloride 💬 		--1件: 171 💬
5569060X----2件: 13, 149 💬
55795% pure ecgc capsules 200MG----1件: 13 💬
5589715X----1件: 90 💬
5599741X----1件: 90 💬
5609742X----1件: 90 💬
56198% dehydrated alcohol----1件: 298 💬
56298-92-0----1件: 107 💬
56399M technetium infliximab----1件: 84 💬
56499MTC-3prgd2----1件: 46 💬
56599MTC-infliximab----1件: 84 💬
56699MTC-rhannexin V-128----2件: 46, 271 💬
56799MTC-S-hynic certolizumab pegol1件: Certolizumab pegol1件: Certolizumab pegol 💬 1件: TNF 💬 66件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬2件: 46, 96 💬
5689mw3811 injection----1件: 85 💬